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Abstract
Concomitant deposition of amyloid -beta protein (Aβ) and neuronal tau as neurofibrillary tangles in the human
brain is a hallmark of Alzheimer disease (AD). Because these deposits increase during normal aging, it has been
proposed that aging brains may also undergo AD-like changes. To investigate the neuropathological changes that
occur in the aging primate brain, we examined 21 brains of cynomolgus monkeys (7–36 years old) for Aβ- and tau-
positive lesions. We found, 1) extensive deposition of Aβ in brains of cynomolgus monkeys over 25 years of age, 2)
selective deposition of 4-repeat tau as pretangles in neurons, and as coiled body-like structures in oligodendroglia-
like cells and astrocytes, 3) preferential distribution of tau in the basal ganglia and neocortex rather than the
hippocampus, and 4) age-associated increases in 30–34 kDa AT8- and RD4-positive tau fragments in sarkosyl-
insoluble fractions. We further labeled tau-positive structures using diaminobezidine enhanced with nickel, and
visualized nickel-labeled structures by energy-dispersive X-ray (EDX) analysis of ultrathin sections. This allowed us to
distinguish between nickel-labeled tau and background electron-dense structures, and we found that tau localized
to 20–25 nm straight filaments in oligodendroglia-like cells and neurons. Our results indicate that the
cytopathology and distribution of tau deposits in aged cynomolgus brains resemble those of progressive
supranuclear palsy (PSP) and corticobasal degeneration (CBD) rather than AD. Thus, even in the presence of Aβ,
age-associated deposition of tau in non-human primates likely does not occur through AD-associated mechanisms.
Keywords: Aged monkey, Progressive supranuclear palsy, Immuno electron microscopy, Energy-dispersive X-ray
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Introduction
Animal models for Alzheimer disease (AD) have been
developed mainly by using genetic modifications of ro-
dents [1]. However, these models have not been able to
provide a platform to develop diagnostic and therapeutic
strategies that can be transferred to clinical practice. The
limitations of these models are mainly derived from their
short life spans, differences in the structural organization
of their brains, and molecular differences in relevant
genes and their products. Furthermore, it is fundamen-
tally unclear whether these models represent sporadic
AD. In contrast, primates may provide a better model for
this disease [2] based on their long life spans, the similar-
ity of their brains to human brains, and the occurrence of
age-associated deposits of amyloid beta (Aβ) and tau in
their brains. Initially, only Aβ deposits were identified in
these primate brains [3, 4]. However, subsequent improve-
ments in rearing prolonged primate life span such that
tau-positive lesions could also be observed [5, 6]. It is now
known that primates exhibit concomitant Aβ and tau
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deposits, and this dual pathology has been proposed to
occur through AD-like pathogenesis [7].
Tau-positive neurons in human AD brains usually ex-
hibit immunoreactivity (IR) for both three repeat (3R) and
four repeat (4R) tau in neurofibrillary tangles (NFTs) [8].
These AD-NFTs consist of tau in paired-helical filaments
(PHFs), even in the early stages of the disease [9]. AD-
NFTs initially develop in the parahippocampal gyrus and
subsequently extend to the limbic system and then to the
neocortex [10]. In contrast to AD, two other diseases with
tau deposition, progressive supranuclear palsy (PSP) and
corticobasal degeneration (CBD), show a distinct path-
ology where 4R tau is selectively deposited [11, 12], and
distribution of tau lesions is not skewed towards the
hippocampus. In addition, tau lesions of PSP and CBD are
often found in glia as tuft-shaped astrocytes, astrocytic
plaques and coiled bodies, while neuronal tau is frequently
found diffusely in the cytoplasm in a pretangle state [13].
Previous studies have found abundant tau lesions in
the glia of aged primate brains [6, 14, 15]. These lesions
were not associated with authentic NFTs, and were
found mainly in the cortex, rather than in the hippocam-
pus, suggesting that their pathology may be distinct from
that of AD. In the present study, we examined brains
from cynomolgus monkeys of different ages in more de-
tail, and found that tau-positive lesions in old animals
exhibited morphological and biochemical features of
PSP/CBD rather than AD.
Materials and methods
Brain sampling from monkeys at different ages
Twenty one brains from cynomolgus monkeys aged 7–36
years (Table 1) were obtained from the Tsukuba Primate
Research Center (TPRC), National Institutes of Biomedical
Innovation, Health and Nutrition (NIBIOHN), Japan. All
animals were bred and maintained in an air-conditioned
room at the TPRC with controlled illumination (12 h light
/ 12 h dark), temperature (25 ± 2 °C), humidity (60 ± 5 %),
and ventilation (10 cycles/h). They were given 70 g of com-
mercial food (CMK-2; CLEA Japan, Inc., Tokyo, Japan),
and 100 g of apples daily, and unlimited access to tap water
[16]. Their health status (e.g., viability, appetite, coat ap-
pearance) was assessed every morning. The maintenance
of animals was conducted according to the rules for animal
care of the TPRC at NIBIOHN for the care, use, and
biohazard countermeasures of laboratory animals. This
study was carried out in strict accordance with the recom-
mendations in the Animal Care and Use Committee of the
NIBIOHN, Japan. The protocol was approved by the Com-
mittee on the Ethics of Animal Experiments of the
NIBIOHN. When a monkey presents clinical symptoms of
injury or illness and was not expected to recover from pain
or morbidity, it was euthanized by intravenous administra-
tion of sodium pentobarbital (>100 mg/Kg body weight).
The postmortem delay between death and sampling was
no more than 1 h in all animals examined. All animal
experiments were conducted according to the guidelines of
the Animal Care and Use Committee of National Center
for Geriatrics and Gerontology (25–38) and NIBIOHN
(DS17-001R5).
Immunohistochemistry
Brain samples were immersion fixed in 4 % paraformal-
dehyde (PFA), cut into serial coronal slices from frontal
to occipital lobes and embedded in paraffin. Five μm-
thick sections were deparaffinized and subjected to ap-
propriate pretreatments and immunohistochemistry with
the antibodies listed in Table 2 [11, 12]. Epitopes of
these antibodies (AT8 [17, 18], RD3 for 3R tau and RD4
for 4R tau [11]), necessary pretreatments, and specificity
for RD3 and RD4 have been described previously as
summarized in Table 2 [12]. Briefly, deparaffinized sec-
tions for RD3 and RD4 immunostains were treated with
potassium permanganate for 15 min followed by 2 %
oxalic acid for 3 min, 100 % formic acid for 30 min each
at room temperature and then heat retrieved with
0.01 M citrate buffer in pressure cooker (115 °C for
10 min). Samples were then incubated in primary
antibodies diluted with phosphate-buffered physiological
saline (PBS) at 4 °C for 2 days, and biotinylated second-
ary antibodies (1:1000, Vector, Burlingame, CA) for 2 h.
After subsequent incubation with streptavidin biotinyl-
ated horseradish peroxidase complex (ABC Elite, Vector,
Burlingame, CA), color development was performed
with diaminobenzidine (DAB) in the presence of imid-
azole and nickel ammonium chloride. For double immu-
nohistochemistry for PHF-tau (AT8) and Aβ42, sections
were initially incubated with AT8, and visualized with
DAB containing nickel ammonium sulfate, which gener-
ates dark purple precipitates. The same section was then
Table 1 Age and sex of the monkeys and presence or absence of AT8 or Aβ-positive lesions in their brains
Age (ys) 7 7 7 7 14 15 15 17 22 24 24 25 28 30 30 31 32 32 35 36 36
M/F F F F F F F F M F F F F F F F M M M F M
AT8 − − − − − − − − − − − − − − + + − + NA + ++
Aβ − − − − − − − − − − + + − + + − + + NA + ++
WB * * * * * * * NA *
Abbreviations: Age age at death, +presence of lesions, −absence of lesions, M male, F female, NA not available, WB Western blot
*samples used for WB
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incubated with an anti-Aβ42 antibody, and visualized
with DAB, which generates brown precipitates.
In order to plot AT8-positive lesions, the entire area of
immunostained-sections was digitalized with a virtual
slide system (VS120, Olympus, Tokyo, Japan). Obtained
images were displayed on Canvas 12 (ACD Systems of
America, Seattle, WA) and each AT8-positive lesion was
classified into neuronal (red ring), astrocytic (green ring)
and oligodendroglia-like (blue spot). Plotting was
performed manually on transparent layers, overlaid on
the original virtual slide images (×10 objective). When
captured images were ambiguous, the nature of each
lesion was assessed from the original slide using a
microscope. Silver impregnation was performed using
Table 2 List of antibodies used in this study
Antibody (clone) Epitope Species Dilution Pretreatment Supplier
PHF-tau (AT8) pS202/pT205(/pS208) [17, 18] mo 1:10,000 none Thermo Fisher, Waltham, MA
RD3 (8E6/C11) KHQPGGGKVQIVYKPV [11] mo 1:3000 KMn, Ox, FA, AC [12] Upstate, Lake Placid, NY
RD4 (1E1/A6) VQIINKKLDLSNVQSKC [11] mo 1:1000 KMn, Ox, FA, AC [12] Upstate, Lake Placid, NY
Aβ42 rb 1:20,000 FA IBL, Fujioka, Japan
Abbreviations: mo mouse, KMn 0.25 % potassium permanganate for 15 min, Ox 2%oxalic acid for 3 min, FA 99%formic acid for 30 min, AC autoclaving in 0.01 M
citrate buffer at 121 °C for 30 min, rb rabbit
Fig. 1 Amyloid beta and tau deposition in the 36-year-old monkey. Double staining for PHF tau (AT8, dark purple or black) and Aβ (brown)
in brain slices from the 36-year-old monkey a. Pyramidal neurons were positive for AT8 (arrow, a). Higher magnification of a temporal lobe
region, indicated by the large rectangle in a, is shown in b, again showing AT8-positive neurons in dark purple, and Aβ-positive deposits in
brown. AT8 immunoreactivity (IR) was abundant in the globus pallidus (arrowhead in a) and in the white matter of the hippocampus (asterisk
in a and d). In higher magnification images of the globus pallidus c, AT8 IR was found along fiber bundles (asterisk) and small round cells
(arrowheads. See Fig. 4 for more details). Brown deposits are macrophages containing hemosiderin. Higher magnification of the hippocampal
white matter (asterisk d and e) revealed AT8-positive oligodendroglia-like cells (arrowheads in e) and fibers (asterisks in e). The hippocampal
white matter (asterisk, f) and pyramidal neurons (arrow, f) were also immunopositive with RD4 (dark purple staining in f) but not for RD3 (data
not shown). Images (a–f) were captured using a virtual slide system VS120 (Olympus, Tokyo, Japan), equipped with “extended focus imaging”.
Multiple images at different focal planes (17 planes with an interval of 0.5 μm) were fused into a single image. a–c, e: double staining for AT8
(dark purple) and Aβ (brown); d: Klüver-Barrera stain; f: RD4 immunostaining counter stained with nuclear fast red. Bars a:5 mm; b:200 μm,
c:100 μm; d, f:1 mm, e:20 μm
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Gallyas and Campbell-Switzer methods on slices
adjacent to those used for immunohistochemistry [19].
Immunoelectron microscopy with diaminobenzidine
A PFA-fixed specimen from the temporal lobe of the
36 year-old monkey was sliced using a sliding micro-
tome. Slices were treated with 0.5 % hydrogen peroxide
for 1 h, and then incubated with AT8 antibody (1:1000)
for more than 10 days at 4 °C. Immunoreactions were
developed using the avidin biotin-peroxidase method de-
scribed above. After washing in 0.1 M phosphate buffer
(PB, pH 7.4), slices were fixed with 2.5 % glutaraldehyde
in PB and postfixed with 2 % osmium tetroxide in PB
for 2 h. They were dehydrated in a graded series of
ethanol concentrations followed by propylene oxide, and
then horizontally embedded in epoxy resin (EPON 812,
TAAB, Aldermaston, UK). Embedded samples were
sectioned into 4 μm-thick serial semi-thin sections.
Lesions were identified based on the DAB-labeled
products under a light microscope. Sections containing
target lesions were adhered on another block of epoxy
resin. Ultrathin sections were cut, stained with uranyl
acetate and lead citrate, and examined under a trans-
mission electron microscope (TEM, JEM-1400, JEOL,
Tokyo, Japan) or a scanning transmission electron
microscope (STEM, Hitachi HD-2700, Hitachi High
Technologies Corporation, Tokyo, Japan). The STEM
was equipped with a cold-field emission gun and
detectors that consist of bright-field, high-angle annular
dark-field and secondary electron detectors to distin-
guish different elements (including nickel, osmium,
lead, uranium) based on their energy spectra. This
was used to identify the presence of these elements
in each STEM pixel in the entire EM field to map
the distribution of each element in relation to under-
lying ultrastructures [9, 20].
Biochemical analyses of monkey brains
The preparation of sarkosyl-insoluble fractions has been
previously described [21]. Briefly, frozen temporal corti-
ces (0.2 g) were homogenized in a glass homogenizer in
4 ml of TBS (10 mM Tris, 150 mM NaCl, pH 7.4)
containing Complete Mini TM proteinase inhibitor
cocktail (Roche Molecular Biochemicals, Penzberg,
Germany) and phosphatase inhibitors (1 mM NaF,
0.4 μM Na3VO4, and 0.5 μM okadaic acid). After centri-
fugation at 24,000 g for 15 min, the supernatant was
collected as the TBS-soluble fraction. Sarkosyl-insoluble,
PHF-enriched fractions were prepared from the TBS-
insoluble precipitates. Precipitates were re-homogenized
in 4 ml of TBS containing 0.32 M sucrose and centri-
fuged at 24,000 g for 15 min. One tenth volume of 10 %
sarkosyl solution was added to supernatants, which were
then vortexed, incubated for 1 h at 37 °C, and centri-
fuged at 150,000 g for 1 h. Resulting pellets were washed
Fig. 2 Pretangle neurons in the hippocampal pyramidal layer of the 36-year-old monkey. Tau IR with AT8 a and that with RD4 b were granular
and diffuse in the neuronal cytoplasm and dendrites, rarely organized into neurofibrillary tangles. Argyrophilia with Gallyas silver impregnation
was limited to a few neurons (c, arrowhead). None of these neurons exhibited fibrillary structures in their cytoplasm. In contrast, numerous
neurofibrillary tangles were stained by Gallyas silver impregnation in the CA1 of a 94-year-old male with AD (d, arrowheads). Scale bar, 50 μm
Uchihara et al. Acta Neuropathologica Communications  (2016) 4:118 Page 4 of 13
in TBS and centrifuged at 150,000 g for 1 h to obtain the
sarkosyl-insoluble fractions (pellets). 10 μg of proteins
from TBS-soluble and the sarkosyl-insoluble fractions
were then subjected to SDS-PAGE, and blotted onto poly-
vinylidene fluoride membranes. Membranes were blocked
with 3 % bovine serum albumin in PBS (pH 7.0) contain-
ing 0.1 % Tween-20 (PBST) (for phosphorylated-tau) or
5 % nonfat dried milk in PBST (for other proteins) for 1 h
at room temperature, and then incubated with primary
antibodies, AT8 (1:500), RD3 (1:1000), or RD4 (1:1000),
overnight at 4 °C. Membranes were then incubated with
horseradish peroxidase-conjugated goat anti-mouse IgG
(Cell Signaling Technology, Danvers, MA) for 1 h at room
temperature. Immunoreactive elements were visualized
using enhanced chemiluminescence (Immobilon Western
Detection Reagents; Millipore, Billerica, MA).
Results
In this cohort, deposits immunoreactive for Aβ were
found in brain sections from primates 24 years of age and
older, while deposits immunoreactive for PHF-tau (AT8)
were found starting at 30 years of age (Table 1). The brain
from the oldest monkey we examined (36 yo) exhibited
numerous tau deposits (dark purple, Fig. 1a, b) as well as
Aβ deposits (brown, Fig. 1a, b). Pyramidal neurons in the
hippocampus exhibited AT8 IR (Fig. 1a, arrow). Because
tau-positive deposits were abundant in the white matter
(Fig. 1a, d, asterisks) and basal ganglia, (Fig. 1a, arrow-
head) particularly in the globus pallidus (GP, c), their dis-
tribution was different from that of AD in the human
brain, which is prevalent in the hippocampus.
In the GP, AT8 immunoreactivity (IR) was found in fiber
bundles (asterisk, c) and small round cells, likely to be
oligodendroglia (arrowheads, c. See Fig. 4 for more
details). AT8 IR was also abundant in the white matter in
the temporal lobe (a, asterisk) and the hippocampus
(asterisks in a and d). Higher magnification of the
hippocampal white matter (e) identified AT8-positive
oligodendroglia-like cells (arrowheads, e) and fibers (aster-
isks, e). Adjacent hippocampal slices demonstrated 4R tau
(RD4, Fig. 1f) IR in pyramidal neurons (arrow, Fig. 1f) and
in the hippocampal white matter (asterisk, Fig. 1f).
Because 3R tau IR was absent in these AT8/RD4-positive
lesions (data not shown), their staining profile was differ-
ent from that of human AD, which is immunopositive for
both 3R and 4R tau [11, 12]. At higher magnifications,
AT8 (Fig. 2a) and RD4 (Fig. 2b) tau immunoreactivity was
diffuse and granular in the neuronal cytoplasm and
dendrites, and rarely organized into NFTs. Argyrophilia
with Gallyas silver impregnation was quite limited (Fig. 2c,
arrowhead) and they were not argyrophilic with Campbell-
Switzer silver impregnation (data not shown). The scarcity
of NTFs, fibrillary structure, and Gallyas silver argyrophilia,
also differs from AD pathology in the human brain (Fig. 2d,
arrowheads).
We observed numerous AT8-positive processes (Fig. 3a,
dark purple, arrowheads), independent of Aβ (Fig. 3a,
brown, asterisk) in the temporal cortex. Similar structures
in the same area were positive exclusively for RD4 (Fig. 3b)
and oriented around blood vessels (Fig. 3b, arrows).
Thorn-shaped astrocytes or granular/fuzzy astrocytes
grouped under the umbrella of “aging-related tau astro-
gliopathy” were not apparent in these monkey brains [22].
AT8-positive oligodendroglia-like cells and threads were
abundant in GP (Fig. 4a) and in the white matter (Fig. 1e).
Both perikarya and threads of these oligodendroglia-like
cells were positive for both Gallyas silver impregnation
(Fig. 4b), and RD4 (Fig. 4c) in adjacent sections, but con-
sistently negative for 3R (Fig. 4d). In summary, AT8/RD4-
positive neurons were pretangle-like but their distribution
was accentuated in pyramidal neurons of Ammon’s horn
Fig. 3 Tau-positive astrocytes around blood vessels. AT8-positive
astrocytes (dark purple staining, indicated by arrowheads) were
found independently of Aβ deposits (brown staining, indicated by
asterisk) in the temporal cortex a. RD4-positive signals (purple
staining), but not for RD3 (data not shown), were found close to
blood vessels (arrows) in the same region b. Scale bars,
a:50 μm, b:20 μm
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(Fig. 1a and f arrow) as in AD. However, AT8/RD4-posi-
tive glial cells in the hippocampal white matter (Fig. 1a, d
and f asterisks) and basal ganglia were conspicuous.
Tau-positive lesions were particularly numerous in the
oldest monkey examined (36 yo Fig. 1). However, these
cytopathological findings, including pretangle forms of tau
in neurons, tau-positive astrocytes, and inclusions in
oligodendroglia-like cells, were also detected in brain
sections from other monkeys older than 30 years of age
(Fig. 5). Similar to the 36-year old monkey, tau-positive le-
sions were seen more frequently in the neocortex than in
the hippocampus (Fig. 5).
Oligodendroglia-like cells in the hippocampal white
matter were identified on AT8/DAB stained sections
embedded in Epon and trimmed for electron micro-
scopic examination (Fig. 6a). In these cells, non-twisted
filaments with a diameter of 20–25 nm were randomly
scattered with occasional parallel streams in the cyto-
plasm (Fig. 6b, inset). Because ultrastructures and DAB
labeling are both electron-dense, distinguishing between
DAB labeled structures and ultrastructures is difficult.
To address this problem, we first immunolabeled with
DAB in the presence of ammonium nickel sulfate, so
that DAB precipitates contained nickel. We next ana-
lyzed sections using STEM and energy dispersive X-ray
(EDX) analysis to identify Ni-specific energy peaks (Fig. 6a,
compare area c, Ni+, with area d, Ni-). By plotting the
presence or absence of Ni in each pixel in the EM field,
we were able to accurately map tau IR. We further show
that the distribution of Ni (Fig. 6e Ni, purple) is
distinct from the distribution of components of non-
specific electron dense regions, including osmium
(Fig. 6f Os, cyan), lead (Fig. 6g Pb, red) or uranium
(Fig. 6h U, green).
When we analyzed neurons using this technique, we
found similar electron-dense labeling in the neuronal cyto-
plasm, sometimes in close contact with the outer nuclear
membrane (Fig. 7). Solid filamentous structures, as seen in
oligodendroglia-like cells, were present, but rare in neurons
(Fig. 7 inset, arrowheads). The scarcity of filamentous struc-
tures in neurons may be correlated with less intense argyro-
philia on Gallyas silver impregnation (Fig. 2c).
To characterize age-associated changes in tau protein
biochemically, we next separated extracts from frozen
temporal lobes of young (7 yo), and old (over 30 yo)
monkeys into TBS-soluble and sarkosyl-insoluble frac-
tions and probed for AT8-positive (Fig. 8a) and RD4-
positive (Fig. 8c) bands by western blotting. In sarkosyl-
insoluble fractions, we identified AT8 or RD4-positive
bands between 30 and 35KDa in aged monkeys
(asterisks) but not in young controls (7 yo). These bands
were not found in TBS-soluble fractions (Fig. 8b), or in
sarkosyl-insoluble fractions probed with RD3 antibodies
(Fig. 8d). Surprisingly, higher molecular complexes at 50–
70 kDa, seen in human brains with tau deposits [23, 24],
were neither detectable in the sarkosyl-insoluble prepara-
tions nor in the TBS-soluble preparations. These findings
were confirmed in duplicate experiments.
Discussion
Aβ and tau-positive deposits in aged monkey brains
Concomitant age-dependent accumulation of Aβ and
neuronal tau deposits in the brains of primates [4, 6] has
Fig. 4 Tau-positive oligodendroglia-like cells and threads in the globus pallidus. In the globus pallidus of the 36 yo monkey, small oligodendroglia-like
cells (arrowheads) and threads (asterisks) were positive with AT8 a. Argyrophilia with Gallyas silver impregnation was also observed b. Adjacent slices
were positive with RD4 c but negative with RD3 d. Extended focus imaging (a–d, see legend of Fig. 1), Scale bar, 20 μm
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led to the proposal that AD-like pathology may occur
during normal aging in primates. However, it has been
unclear whether these deposits are really representative
of AD pathogenesis or not.
PSP-like cytopathological alterations in aged monkey
brains
In all brains examined in this study, tau-positive struc-
tures exhibited immunoreactivity for 4R, but not 3R tau.
Tau-positive structures were also argyrophilic with Gal-
lyas, but not with Campbell-Switzer silver impregnation.
This cytopathology is different from that of AD, which
usually exhibits immunoreactivity for both 3R and 4R
tau, and argyrophilia with both Gallyas and Campbell-
Switzer silver impregnations [19]. Instead, these pheno-
types suggest that a PSP or CBD-like cytopathology may
occur in brains of aged primates. Supporting this idea,
the 4R-positive structures that we identified around
blood vessel in old primates (Fig. 3b) are similar to tau-
positive structures identified in tuft-shaped astrocytes in
PSP and astrocytic plaques in CBD [25]. Further, we did
not observe tau IR in neurites around senile plaques
(Fig. 3a, asterisk), suggesting that most tau-positive
structures in old primate brains may be of glial origin
similar to human PSP/CBD, which are not frequent in
aged human brains with AD pathologies. Moreover,
these tau-positive astrocytes are morphologically differ-
ent from thorn-shaped astrocytes, granular/fuzzy astro-
cytes grouped under the umbrella of “aging-related tau
astrogliopathy [22]” Consistent with our results, Kiati-
pattanasakul and colleagues [26] previously described
PSP-like tau deposition in neurons and glia in an aged
(35 yo) albino cynomolgus monkey. They also observed
Gallyas-positive glia in the basal ganglia, thalamus,
brainstem and the white matter as well as NFTs in
the thalamus. However, they proposed that the occur-
rence of PSP-like cytopathology in their monkey brain
was exceptional. In our study, however, we observed
similar neuronal and glial cytopathological alterations
of tau in 5 out of 7 monkeys over 30 years of age
(Table 2, Fig. 5), suggesting that PSP-like cytopatholo-
gies may instead represent a common aspect of aged
monkey brains.
PSP-like distribution of tau cytopathologies in aged
monkey brains
Although tau-positive lesions were found in temporal and
hippocampal areas in the oldest monkey examined (36 M,
Fig. 1), lesions were also abundant in the white matter and
basal ganglia, predominantly in oligodendroglia-like cells
and as intrafascicular threads. In other monkeys over
30 years of age, lesions were present in the frontal and
temporal neocortices and basal ganglia rather than in the
hippocampus (Fig. 5). Again, this distribution of tau-positive
lesions is reminiscent of the aged cynomolgus monkey
described by Kiatipattanasakul et al. [26], and suggest cyto-
pathological alterations characteristic of PSP rather than
those of AD [10, 13]. A similar cortical distribution of tau
Fig. 5 Frontal-dominant distribution of tau-positive neurons and glia.
AT8-positive structures were plotted onto coronal slices with astrocytic
signals labeled as green rings, neuronal signals labeled as red rings and
signals in oligodendroglial cells labeled as blue spots. Slices are displayed
from the left (anterior) to the right (posterior), with Case IDs indicated for
each row (eg, “30 F2” indicates “30-year-old female, case no 2”). AT8-
positive lesions were detectable after age 30, but these were few in
number. These lesions were predominantly in the neocortex rather than
in the hippocampus. Amy:amygdala; Cal:calcarine sulcus; CC:corpus callo-
sum; Cd:caudate nucleus; Cl:claustrum; Hipp:hippocampus; IP:intraparietal
sulcus; LGB:lateral geniculate body; LS:lunate sulcus; PO:parietooccipital
sulcus; PS:principal sulcus; Put:putamen; SupT:superior temporal sulcus;
OT:occipitotemporal sulcus; Th:thalamus; Scale bar, 2 mm
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lesions, different from human AD, has been reported in the
brains of gorilla [14, 15]. Taken together, tau-positive lesions
in aged non-human primate brains do not necessarily repre-
sent AD-like pathogenesis even though Aβ deposits may be
present in the same specimens.
EDX isolation of DAB-Ni labeling from the background
In our previous studies [20], we distinguished between
electron-dense areas due to immunolabeling from back-
ground electron-dense areas by labeling with Quantum
dot nanocrystal (QD). This EDX detection of the QD
constituents, selenium and cadmium, was further ex-
tended to map these elements by highlighting against
background structures (EDX mapping) [9]. In our
current study, we developed a novel technique of immu-
noelectron microscopy (immuno EM) by applying this
EDX mapping on ultrathin sections, developed with
DAB enhanced with nickel ammonium sulfate. Because
EDX spectra can detect the presence of nickel in DAB
decorated areas (Fig. 6a, area c, Ni+), and because nickel
is not found in background areas (Fig. 6a, area d, Ni-), it
was possible to map pixels containing nickel over the
entire EDX field (Fig. 6e, Ni, violet) to identify specific
DAB-positive regions. Similar maps for peaks of os-
mium (Fig. 6f, Os, cyan), lead (Fig. 6g, Pb, red) and ur-
anium (Fig. 6h, U, green) identified background
Fig. 6 Immunoelectron microscopy of tau-positive oligodendroglia-like cells. Oligodendroglia-like cells a labeled with AT8/diaminobenzidine (DAB,
Scale bar, 1 μm). Nickel (Ni) ammonium sulfate was used to enhance the DAB signals. A higher magnification image of the white box in the upper left
of a is shown in b and shows AT8 labelled 20–25 nm diameter straight filaments (scale bar:0.2 μm). The specificity of this labeling was confirmed by
energy-dispersive X-ray (EDX) analysis. A nickel peak (Ni+) was detected in areas with DAB precipitates (area c) but not in background areas (Ni-, area d).
EDX mapping of this Ni peak identified areas labeled specifically by DAB (e, Ni, purple). In contrast, EDX mapping for osmium (f, Os, cyan), lead (g, Pb, red)
and uranium (h, U, green), identified background electron-dense areas. For a high resolution image of Fig. 6 please see Additional file 1
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electron-dense regions that were qualitatively different
from the Ni-specific maps. This approach, easily per-
formed by analyzing DAB-Ni decorated sections with
EDX, may greatly expand the utility and reliability of
DAB-Ni decorated EM preparations by distinguishing
specific signals from otherwise indistinguishable back-
grounds of similar electron density.
PSP-like ultrastructure of tau filaments in
oligodendroglia-like cells
4R tau labeling and Gallyas argyrophilia were more intense
in oligodendroglia-like cells in the white matter (Fig. 4b)
than in neurons (Fig. 2c). In these oligodendroglia-like cells,
AT8-labeled fibrils were 20–25 nm in diameter without
apparent constriction (Fig. 6b), similar to those reported in
Fig. 7 Immunoelectron microscopy of a neuron containing tau-positive signals. Tau immunolabeled filaments (arrowheads) were observed
around the nuclear membrane (inset, bar:0.2 μm), although tau-positive deposits were not abundant in neurons (scale bar, 5 μm). For a high
resolution image of Fig. 7 please see Additional file 2
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tau-positive fibrils in oligodendroglia in PSP brains [27]. In
contrast, in oligodendrotcytes in AD brains, mixtures of
straight filaments with a diameter of 16 nm, and irregularly
constricted filaments with greatest width of 30 nm have
been described [28].
In our study, neurons in aged monkeys were positive,
specifically for 4R tau, but argyrophilia with Gallyas was
much less intense, suggesting an early, premature state of
tau deposition, and aggregation as pretangle neurons. It
was possible to identify some AT8-decorated fibrils in the
neuronal cytoplasm (Fig. 7 inset, arrowheads), but these
were much less abundant than in oligodendrocytes, and
their random arrangement without forming PHFs resem-
bles pretangle neurons in CBD [9].
PSP-like tau fragments in aged monkey brains
The sarkosyl-insoluble fraction from aged monkey brains
(32–36 yo) contained 30–34 kDa bands positive for AT8
and RD4, not found in young controls (7 yo) (Table 1,
Fig. 8). Tau-positive bands in this molecular range have
been reported to be specific to PSP, and are distinct from
AD [23, 24]. Curiously, full-length hyperphosphorylated tau
(60, 64 and 68 kDa, Fig. 8a, c) was not detected in sarkosyl-
Fig. 8 Temporal lobe homogenates probed with AT8 and isoform-specific antibodies, RD3 and RD4. In sarkosyl-insoluble preparations, AT8-
positive a and RD4-positive c bands were detectable between 30 and 35KDa in aged monkeys (asterisk 32, 35, 36 and 36 years-old) but not in
young controls (7 years-old). This age associated increase is neither evident in Tris-soluble preparations probed by AT8 b, nor in sarkosyl-insoluble
preparations probed with RD3 d. Higher molecular complex at 50–70 kDa, seen in human brain with tau deposits, were not detectable in either
sarkosyl-insoluble preparations or tris-soluble preparations
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insoluble fractions from young or aged monkeys, and it re-
mains to be clarified how these shorter tau fragments are
generated. The absence of full-length tau in these fractions
may be related to scarcity of neuronal tau (Fig. 7), while
solid fibrillary structures in oligodendroglia-like cells (Fig. 6)
may correspond to the 30–34 kDa sarkosyl-insoluble frag-
ments. Thus, it is possible that neuronal tau in human
brains with PSP consists mainly to full-length tau, while
glial tau consists of the 30–34 kDa fragments, although this
interpretation remains to be proved.
Is the pathology of aged cynomolgus brains AD-like or
PSP-like?
Preferential limbic-hippocampal accumulation of tau-
positive neurons, similar to human AD pathology, has
been described in aged baboons [29], captive cheetahs
(Acinonyx jubatus) [7], wild Tsushima leopard cats [30],
and domestic cats [31]. Moreover, aged domestic cats’
brains exhibit both 3R and 4R tau immunoreactivity in
sarkosyl-insoluble brain fractions [31], again consistent
with characteristics of AD. However, in this study, we
found that tau lesions in aged monkey brains are similar
to lesions of PSP, and distinct from those of AD, even in
the presence of coexisting Aβ deposits (Table 1). Consist-
ent with our results, Rosen and colleagues [32] identified
tau lesions not associated with Aβ plaques in a 41 yo
chimpanzee. These lesions were most abundant in the
prefrontal cortex, with decreasing amounts in the tem-
poral and occipital cortices, a distribution distinct from
that of AD, which typically shows a hierarchical distribu-
tion around the hippocampus [10]. Tau lesions were also
found in the GP and neostriatum in this chimpanzee, sug-
gesting a PSP-like origin for these lesions, despite the
presence of Aβ. Similar neocortical predominance of tau
lesions has been reported in Microcebus murinus [33] and
gorillas [14, 15]. Further, Oikawa and colleagues identified
tau-positive neurons and glia, with less evident argyro-
philia with Gallyas silver impregnation [6]. This result is
consistent with repeated observations that true NFTs
are extremely rare in nonhuman primate brains [34,
35], and suggests a premature state of tau deposition as
“pretangle neurons” in aged cynomolgus monkeys.
Finally, widespread development of tau/Gallyas-positive
neurons and glia (tufts of abnormal fibers, thorn-
shaped astrocytes, glial coiled bodies and argyrophilic
threads) in the basal ganglia and brainstem nuclei have
been reported in a 35 yo albino cynomolgus monkey
[26]. Even with coexisting Aβ deposits, these tau-
positive structures are more consistent with a PSP-like
rather than AD-like pathology.
Conclusions
It is generally accepted that the co-existence of Aβ de-
posits and tau-positive lesions provides a firm histological
basis for the diagnosis of AD. However, close scrutiny of
tau-positive structures in our cohort of cynomolgus mon-
keys demonstrated a constellation of pathological findings,
such as pretangle neurons and tau-positive glia (oligo-
dendrocyte-like cells and astrocytes) prevalent in the neo-
cortex and basal ganglia, which may favor the histological
diagnosis of PSP rather than AD. Indeed, some of these
PSP-like features of tau have been described previously in
animal brains. In human brains, as well, Aβ deposits have
been described in PSP brains [36, 37]. In human PSP, tau-
positive lesions seem to occur independently of Aβ de-
posits, and it is unlikely that Aβ deposition induces PSP-
like tau pathology even if the former precedes the latter.
Our results suggest that it is necessary to recognize how
Aβ and tau are represented in animal brains without being
preoccupied by AD-pathology models.
Additional files
Additional file 1: Immunoelectron microscopy of tau-positive
oligodendroglia-like cells. (JPG 7.94 mb)
Additional file 2: Immunoelectron microscopy of a neuron containing
tau-positive signals. (JPG 8.57 mb)
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